NanoString Technologies, Inc. (NSTGQ)
OTCMKTS: NSTGQ · Delayed Price · USD
0.290
+0.005 (1.75%)
Apr 26, 2024, 3:59 PM EDT - Market closed
NanoString Technologies Revenue
NanoString Technologies had revenue of $162.47M in the twelve months ending September 30, 2023, with 20.09% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $48.09M with 62.79% year-over-year growth. In the year 2022, NanoString Technologies had annual revenue of $127.26M, a decrease of -12.28%.
Revenue (ttm)
$162.47M
Revenue Growth
+20.09%
P/S Ratio
0.09
Revenue / Employee
$295,405
Employees
550
Market Cap
13.95M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 127.26M | -17.82M | -12.28% |
Dec 31, 2021 | 145.09M | 27.77M | 23.67% |
Dec 31, 2020 | 117.32M | -8.25M | -6.57% |
Dec 31, 2019 | 125.57M | 18.84M | 17.65% |
Dec 31, 2018 | 106.73M | -8.17M | -7.11% |
Dec 31, 2017 | 114.91M | 28.42M | 32.86% |
Dec 31, 2016 | 86.49M | 23.82M | 38.01% |
Dec 31, 2015 | 62.67M | 15.07M | 31.67% |
Dec 31, 2014 | 47.59M | 16.19M | 51.56% |
Dec 31, 2013 | 31.40M | 8.43M | 36.70% |
Dec 31, 2012 | 22.97M | 5.17M | 29.06% |
Dec 31, 2011 | 17.80M | 6.07M | 51.75% |
Dec 31, 2010 | 11.73M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
NSTGQ News
- 10 days ago - Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process - GeekWire
- 10 days ago - NanoString Technologies to Be Acquired by Bruker Corporation - Business Wire
- 23 days ago - NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research (AACR) Conference - Business Wire
- 6 weeks ago - Healthcare investment firm Patient Square Capital agrees to acquire NanoString assets for $220M - GeekWire
- 6 weeks ago - Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies - Business Wire
- 2 months ago - European UPC Court of Appeal Overturns Injunction Impacting NanoString's CosMx Products, Company to Immediately Resume Sales in 16 EU Countries - Business Wire
- 2 months ago - NanoString Announces Completion of Financing to Support Restructuring Process - Business Wire
- 2 months ago - NanoString stock sinks 70% as Seattle biotech company enters bankruptcy process - GeekWire